SCA
DXCM icon

Spearhead Capital Advisors’s DexCom DXCM Stock Holding History

Spearhead Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,472
Closed -$316K – 188
2022
Q1 		$316K Sell
2,472
-2,116
-46% -$231K 0.04% 125
2021
Q4 		$616K Buy
4,588
+8
+0.2% +$1.15K 0.07% 83
2021
Q3 		$626K Buy
4,580
+44
+1% +$5.55K 0.08% 78
2021
Q2 		$484K Buy
4,536
+472
+12% +$45.3K 0.07% 105
2021
Q1 		$365K Buy
4,064
+168
+4% +$15.8K 0.05% 112
2020
Q4 		$360K Buy
3,896
+144
+4% +$12.9K 0.06% 127
2020
Q3 		$387K Buy
3,752
+168
+5% +$17.6K 0.07% 97
2020
Q2 		$363K Buy
3,584
+504
+16% +$45.1K 0.08% 85
2020
Q1 		$207K Buy
+3,080
New +$192K 0.06% 95

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spearhead Capital Advisors's DXCM Position: Q2 2022 in Review

Spearhead Capital Advisors sold out of DexCom (DXCM) in Q2 2022, closing a stake of 2,472 shares — an estimated $316K sold.

Spearhead Capital Advisors first reported a position in DXCM in Q1 2020 and held it in 9 quarters. The position peaked at $626K in Q3 2021. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Spearhead Capital Advisors reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Spearhead Capital Advisors sold 2,472 DexCom shares in Q2 2022, an estimated $316K.
  • Spearhead Capital Advisors first reported a position in DexCom in Q1 2020 and held it in 9 quarters.
  • Spearhead Capital Advisors's DexCom position peaked at $626K in Q3 2021.
  • 798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Spearhead Capital Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.